abstract because of the central role of the transcription factor nuclear factor-kappab (nf-kappab) in cell survival and proliferation in human multiple myeloma (mm), we explored the possibility of using it as a target for mm treatment by using curcumin (diferuloylmethane), an agent known to have very little or no toxicity in humans.